Atlas Trials

A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

Clinical trial NCT01060254 · TERMINATED

Trial details

NCT number
NCT01060254
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystitis, InterstitialUrologic DiseasesUrinary Bladder DiseasesCystitis
Start date
2010-04-06
Primary completion
2011-06-24
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.